Autolus Therapeutics
AUTL
#6816
Rank
HK$3.90 B
Marketcap
HK$14.69
Share price
-3.08%
Change (1 day)
-69.27%
Change (1 year)

Revenue for Autolus Therapeutics (AUTL)

Revenue in 2024 (TTM): HK$78.98 Million

According to Autolus Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$78.43 Million. In 2023 the company made a revenue of HK$13.26 Million a decrease over the revenue in the year 2022 that were of HK$48.39 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Autolus Therapeutics from 2019 to 2024

2020202120222023$20M$40M$60M$80Mcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$78.98 M495.57%
2023 HK$13.26 M-72.6%
2022 HK$48.39 M166.37%
2021 HK$18.16 M304.08%
2020 HK$4.49 M-77.89%
2019 HK$20.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA